QuiaPEG

Technology

 
PEGylation
Releasable PEGylation
Biobetters and prodrugs
R&D
Intellectual Property Rights

R&D

Drug development projects 

Based on well-defined selection criteria, the company has chosen a few potential candidate substances for continued development. One of these development projects is within metabolic diseases. Another project is in the field of inflammatory diseases where work has given positive indications. Both projects have a significant market potential in areas where there is a great need for improved drugs.

Contact
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
Sweden
+46 (0) 70 693 12 53
info@quiapeg.com

User terms & privacy policy
Send a message